Country Maid Inc Com MDAI 深 滬
已收盤 12-19 16:00:00 美东时间
1.55
+0.080
+5.44%
華盛通- 最 高1.57
- 今 開1.50
- 成交量 28.88万股
- 最 低 1.49
- 昨 收 1.47
- 總市值 4756.78万
- 52周最高 3.25
- 市盈率 靜 --
- 換手率 0.94%
- 52周最低 1.04
- 委 比 -46.52%
- 總股本 3068.89万
- 歷史最高 19.50
- 量 比 1.14
- 振 幅 5.44%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
BTIG Maintains Buy on Spectral AI, Lowers Price Target to $3
BTIG analyst Ryan Zimmerman maintains Spectral AI (NASDAQ:MDAI) with a Buy and lowers the price target from $3.5 to $3.
11-12 19:05
电话会总结 ｜ Spectral AI(MDAI)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Spectral AI业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 公司将2025年营收指导从2150万美元下调至1850万美元，下调幅度为300万美元，主要因BARDA Project BioShield合同活动减少及美国政府停摆的时间影响。 **盈利状况：** 2025年第三季度净亏损360万美元，较2024年同期的150万美元净亏损大幅增加210万美元。前九个月累计净亏损860万美元，较2024年同期的740万美元增加120万美元。 **现金状况：** 截至2025年9月30日，现金及现金等价物余额为105
11-12 12:18
Spectral AI Lowers FY2025 Sales Guidance from $21.500M to $18.500M vs $21.507M Est
Spectral AI (NASDAQ:MDAI) lowers FY2025 sales outlook from $21.500 million to $18.500 million vs $21.507 million estimate.
11-12 05:02
Spectral AI Q3 EPS $(0.13) Misses $(0.08) Estimate, Sales $3.792M Miss $5.063M Estimate
Spectral AI (NASDAQ:MDAI) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 56.63 percent. This is a 62.5 percent decrease over losses of $(0.08) per share from the
11-12 05:01
Earnings Scheduled For November 11, 2025
Companies Reporting Before The Bell • Gogoro (NASDAQ:GGR) is estimated to repor...
11-11 19:11
Spectral AI raises $7.6 Million of Additional Growth Capital
Spectral AI, Inc. announced a $7.6 million offering to expand its DeepView® System for faster, more accurate wound care diagnostics. The offering includes 4 million shares at $1.90 each and warrants exercisable at $2.51. Chairman J. Michael DiMaio highlighted the funding’s role in advancing DeepView’s clinical use and commercial readiness by 2026. Northland Capital Markets acted as the placement agent, while Reed Smith served as counsel. The comp...
10-23 12:30
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
<p align="justify">Spectral AI, Inc., a Dallas-based AI company focused on medical diagnostics for wound care, has been named to TIME's World's Top HealthTech Companies 2025 list. The list recognizes leading innovators advancing healthcare globally through technology, with 400 companies selected based on financial performance, reputation analysis, and online engagement. J. Michael DiMaio, M.D., Chairman of Spectral AI, expressed that this recogni...
09-19 12:00
$504 Billion AI Healthcare Revolution Accelerates as Corporate Giants Launch Next-Gen Platforms
USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Aug. 26, 2025 /PRNewswire/ -- USA News Group News Commentary – The healthcare AI buying spree has re...
08-26 20:54
Spectral AI Raises FY2025 Sales Guidance from $20.500M-$21.500M to $21.500M vs $21.898M Est
Spectral AI (NASDAQ:MDAI) raises FY2025 sales outlook from $20.500 million-$21.500 million to $21.500 million vs $21.898 million estimate.
08-13 04:04
